Fullerton, CA, United States of America

Gary J Beck

USPTO Granted Patents = 13 



Average Co-Inventor Count = 3.8

ph-index = 6

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 2002-2018

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovations of Gary J Beck

Introduction

Gary J Beck is a notable inventor based in Fullerton, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in ophthalmic treatments. With a total of 13 patents to his name, Beck's work has had a considerable impact on the management of glaucoma and related conditions.

Latest Patents

One of his latest patents involves a combination of brimonidine and timolol for topical ophthalmic use. This patent discloses pharmaceutical compositions that comprise brimonidine and timolol for topical ophthalmic delivery. The method of treatment includes administering this composition when indicated for glaucoma and associated conditions such as elevated intraocular pressure in the eyes of humans.

Career Highlights

Throughout his career, Gary J Beck has worked with prominent companies in the pharmaceutical industry, including Allergan, Inc. and Allergan Sales, Inc. His expertise in developing innovative treatments has positioned him as a key figure in the field.

Collaborations

Beck has collaborated with several professionals in his field, including Chin-Ming Chang and Cynthia C Pratt. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Gary J Beck's contributions to pharmaceutical innovations, particularly in ophthalmic treatments, highlight his role as a significant inventor. His work continues to influence the management of eye conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…